Average Co-Inventor Count = 3.75
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Mesoblast International Sarl (8 from 39 patents)
2. Genentech, Inc. (4 from 3,221 patents)
3. Celera Corporation (2 from 98 patents)
4. Osiris Therapeutics, Inc. (71 patents)
14 patents:
1. 11389484 - Mesenchymal stem cells and uses therefor
2. 10960025 - Mesenchymal stem cells and uses therefor
3. 10828334 - Mesenchymal stem cells and uses therefor
4. 10729727 - Mesenchymal stem cells and uses therefor
5. 10716814 - Mesenchymal stem cells and uses therefor
6. 10668101 - Mesenchymal stem cells and uses therefor
7. 9943547 - Mesenchymal stem cells and uses therefor
8. 9694035 - Mesenchymal stem cells and uses therefor
9. 8524238 - Cancer targets and uses thereof
10. 8178082 - Methods for up-regulating PAP1 in animals suffering from pancreatic disorders
11. 8168586 - Cancer targets and uses thereof
12. 7445905 - Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
13. 7226591 - Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
14. 6551799 - Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders